GZMB and lobular neoplasia: Clinical prognostic studies have further confirmed the clinical value of MAIT cells—patients with LN with a higher frequency of peripheral MAIT cells, lower expression of the proliferation marker Ki‐67, and lower GZMB expression at baseline are more likely to achieve complete renal remission after receiving immunosuppressive induction therapy [190].